(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MUSREFCY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

MUSREFCY

ST13

US500000079424974

Class

5

Filing

79424974

Registration

8340008

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

07/14/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

04/22/2025

Registration date

07/14/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2026

Last transaction

07/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

LOREDO GASPAR,ALONSO

Law office

O30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

TAIHO PHARMACEUTICAL CO., LTD.

Representatives

Norm J. Rich Foley & Lardner LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Publications

History of USPTO decisions and trademark events.

19 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/26/2026

PUBO

PUBLISHED FOR OPPOSITION

05/26/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/28/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/27/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/27/2026

RFNT

REFUSAL PROCESSED BY IB

11/30/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/09/2025

RFRR

REFUSAL PROCESSED BY MPU

11/09/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/23/2025

CNRT

NON-FINAL ACTION WRITTEN

09/22/2025

DOCK

ASSIGNED TO EXAMINER

09/15/2025

MAFR

APPLICATION FILING RECEIPT MAILED

06/06/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/06/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/05/2025

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

05/29/2025

Continuous trademark protection

Get notified about every new filing that threatens MUSREFCY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.